Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of Family Medicine and Primary Care|July 29, 2021
COVID-19 seropositivity among non-medical frontline office staff from two cities in Rajasthan, IndiaVidhi Jain, Manoj Kumar Gupta, Malika Grover, et al.
Seminars in Cancer Biology|May 29, 2020
Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancementVaishali Aggarwal, Hardeep Singh Tuli, Mousumi Tania, et al.
Iscience|November 16, 2020
Activation of EPHA2-ROBO1 Heterodimer by SLIT2 Attenuates Non-canonical Signaling and Proliferation in Squamous Cell CarcinomasSaumya Srivastava, Ka Ming Pang, Mari Iida, et al.
Oncogenesis|September 6, 2019
EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesotheliomaYi-Hung Carol Tan, Saumya Srivastava, Brian M Won, et al.
Iscience|August 9, 2023
Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitorsLinlin Guo, Atish Mohanty, Sharad Singhal, et al.
Iscience|September 18, 2020
A Non-genetic Mechanism Involving the Integrin β4/Paxillin Axis Contributes to Chemoresistance in Lung CancerAtish Mohanty, Arin Nam, Alex Pozhitkov, et al.
Indian Dermatology Online Journal|October 3, 2024
Development of Indian Council of Medical Research (ICMR) Standard Treatment Workflows for Skin Diseases: A Step Toward Universal Health CoverageAnanta Khurana, Ashoo Grover, Deepika Pandhi, et al.
Biomolecules|January 21, 2022
Dynamic Phenotypic Switching and Group Behavior Help Non-Small Cell Lung Cancer Cells Evade ChemotherapyArin Nam, Atish Mohanty, Supriyo Bhattacharya, et al.
Iscience|November 2, 2020
Erratum: A Non-genetic Mechanism Involving the Integrin β4/Paxillin Axis Contributes to Chemoresistance in Lung CancerAtish Mohanty, Arin Nam, Alex Pozhitkov, et al.
Molecular Cancer Therapeutics|July 13, 2021
Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung CancerTamara Mirzapoiazova, Gang Xiao, Bolot Mambetsariev, et al.
Pageof 7